zadnja posodobitev :
19/11/2024
raziskovalne skupine - Department of Pharmaceutical and Pharmacological Sciences, University of Padua   pdf  
Italija
univerza
Department of Pharmaceutical and Pharmacological Sciences, University of Padua
Padoue
Email
Viri   Viri   (1)  
1
Prolonging the stability of cetuximab (Erbitux®) and panitumumab (Vectibix®): An orthogonal assessment of physicochemical, biological and microbiological properties of original opened glass vials and diluted saline preparations.
Carpanese D, Rossi V, Di Paolo V, Quintieri L, Penna Zuccolotto G, Sebellin J, Saran C, Pipitone F, Miolo G, de Diana E et al. (valentina.rossi@iov.veneto.it)
Int J Pharm - 2024 - ; 649: 123643.

Seznami   molekule študiral   (2)  
rak drog Brizgalka Cetuximab
rak drog Brizgalka Panitumumab

  Mentions Légales